MedTrace Logo

Corticosteroids as Rescue Therapy for the Late Phase of Acute Respiratory Distress Syndrome

NCT00295269 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 200

Last updated 2006-05-09

No results posted yet for this study

Summary

The purpose of this study is to assess innovative treatment methods in patients with adult respiratory distress syndrome (ARDS) as well as those at risk of developing ARDS.

Conditions

  • Acute Respiratory Distress Syndrome
  • Lung Diseases

Interventions

DRUG

Mythylprednisolone

Sponsors & Collaborators

  • National Heart, Lung, and Blood Institute (NHLBI)

    lead NIH

Principal Investigators

  • Edward Abraham · University of Colorado, Denver

  • William Fulkerson · Duke University

  • Leonard Hudson · University of Washington

  • Paul Lanken · University of Pennsylvania

  • Michael Matthay · University of California

  • Alan Morris · Latter Day Saints Hospital

  • David Schoenfeld · Massachusetts General Hospital

  • Henry Silverman · University of Maryland

  • Galen Toews · University of Michigan

  • Arthur Wheeler · Vanderbilt University

  • Herbert Wiedemann · The Cleveland Clinic

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
FACTORIAL

Eligibility

Min Age
13 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
1997-03-31
Completion
2005-09-30

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00295269 on ClinicalTrials.gov